SAFRA CATZ - 27 Jun 2025 Form 4 Insider Report for ORACLE CORP (ORCL)

Role
Chief Executive Officer, Director
Signature
/s/ Aimee Weast by Aimee Weast, Attorney in Fact for Safra Catz (POA Filed 03-21-19)
Issuer symbol
ORCL
Transactions as of
27 Jun 2025
Transactions value $
-$202,794,565
Form type
4
Filing time
01 Jul 2025, 17:10:59 UTC
Previous filing
26 Jun 2025
Next filing
11 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CATZ SAFRA Chief Executive Officer, Director C/O DELPHI ASSET MGMT CORPORATION, 200 S. VIRGINIA ST., SUITE 625, RENO /s/ Aimee Weast by Aimee Weast, Attorney in Fact for Safra Catz (POA Filed 03-21-19) 01 Jul 2025 0001205005

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORCL Common Stock Options Exercise $64.4M +1.26M +112.69% $51.13 2.38M 27 Jun 2025 Direct
transaction ORCL Common Stock Sale -$103M -492K -20.66% $210.35 1.89M 27 Jun 2025 Direct F1, F2
transaction ORCL Common Stock Sale -$38.3M -181K -9.6% $211.32 1.71M 27 Jun 2025 Direct F1, F3
transaction ORCL Common Stock Sale -$24.3M -114K -6.7% $212.75 1.59M 27 Jun 2025 Direct F1, F4
transaction ORCL Common Stock Sale -$70.4M -330K -20.7% $213.64 1.26M 27 Jun 2025 Direct F1, F5
transaction ORCL Common Stock Sale -$30.9M -144K -11.41% $214.25 1.12M 27 Jun 2025 Direct F1, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORCL Stock Option Options Exercise $0 -1.26M -100% $0.00 0 27 Jun 2025 Common Stock 1.26M $51.13 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Sale of shares pursuant to Rule 10b5-1 Plan adopted on September 25, 2024.
F2 This transaction was executed in multiple trades at prices ranging from $209.98 to $210.975. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $210.98 to $211.91. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $212.00 to $212.995. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $213.00 to $213.995. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F6 This transaction was executed in multiple trades at prices ranging from $214.00 to $214.63. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F7 Represents 2/7 of the number of shares subject to a performance-based option that vested upon certification of a performance goal by the Compensation Committee.